Monday, October 12, 2015 9:53:05 AM
Wingstop Inc. To Announce Third Quarter 2015 Financial Results On November 5, 2015
GLOBENEWSWIRE
Oct 12, 2015 8:00 AM EDT
DALLAS, Oct. 12, 2015 (GLOBE NEWSWIRE) -- Wingstop Inc. (NASDAQ:WING) today announced that it will host a conference call and webcast to discuss its third quarter 2015 financial results on Thursday, November 5, 2015 at 5:00 PM Eastern Time.
Hosting the conference call will be Charlie Morrison, President and Chief Executive Officer, and Mike Mravle, Chief Financial Officer. A press release with third quarter 2015 financial results will be issued that same day, shortly after the market closes.
The conference call can be accessed live by dialing 855-327-6837 or for international callers by dialing 631-982-4565. A replay will be available two hours after the call and can be accessed by dialing 877-870-5176 or for international callers by dialing 858-384-5517; the passcode is 116117. The replay will be available through Thursday, November 12, 2015.
The conference call will also be webcast live and later archived on the investor relations section of Wingstop's corporate website at ir.wingstop.com under the 'News & Events' section.
Recent WING News
- Wingstop Inc. Reports Fiscal First Quarter 2024 Financial Results • PR Newswire (US) • 05/01/2024 12:01:00 PM
- Wingstop Elevates 4/20 with a New Strain of T.H.C. (The Hot Chili) Rub • PR Newswire (US) • 04/17/2024 12:15:00 PM
- Wingstop Inc. To Announce Fiscal First Quarter 2024 Financial Results On May 1, 2024 • PR Newswire (US) • 04/02/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:59:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:58:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:50:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:49:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 11:20:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 11:19:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 11:18:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 11:15:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 11:14:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 11:12:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 10:21:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:57:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:50:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:49:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:46:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2024 01:41:38 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 11:26:47 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 11:14:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:04:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:06:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:04:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 10:58:03 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM